![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TNFRSF4 |
Gene summary for TNFRSF4 |
![]() |
Gene information | Species | Human | Gene symbol | TNFRSF4 | Gene ID | 7293 |
Gene name | TNF receptor superfamily member 4 | |
Gene Alias | ACT35 | |
Cytomap | 1p36.33 | |
Gene Type | protein-coding | GO ID | GO:0001775 | UniProtAcc | P43489 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
7293 | TNFRSF4 | LZE4T | Human | Esophagus | ESCC | 1.70e-03 | 3.36e-01 | 0.0811 |
7293 | TNFRSF4 | LZE7T | Human | Esophagus | ESCC | 2.56e-05 | 6.60e-01 | 0.0667 |
7293 | TNFRSF4 | LZE6T | Human | Esophagus | ESCC | 1.62e-02 | 4.91e-01 | 0.0845 |
7293 | TNFRSF4 | P74T-E | Human | Esophagus | ESCC | 1.26e-08 | 3.04e-01 | 0.1479 |
7293 | TNFRSF4 | P130T-E | Human | Esophagus | ESCC | 5.17e-27 | 6.94e-01 | 0.1676 |
7293 | TNFRSF4 | C04 | Human | Oral cavity | OSCC | 2.08e-02 | 5.12e-01 | 0.2633 |
7293 | TNFRSF4 | C21 | Human | Oral cavity | OSCC | 7.81e-18 | 8.34e-01 | 0.2678 |
7293 | TNFRSF4 | C30 | Human | Oral cavity | OSCC | 1.22e-08 | 2.43e-01 | 0.3055 |
7293 | TNFRSF4 | C51 | Human | Oral cavity | OSCC | 2.23e-07 | 3.70e-01 | 0.2674 |
7293 | TNFRSF4 | C06 | Human | Oral cavity | OSCC | 4.07e-10 | 9.70e-01 | 0.2699 |
7293 | TNFRSF4 | C08 | Human | Oral cavity | OSCC | 1.68e-08 | 1.80e-01 | 0.1919 |
7293 | TNFRSF4 | LN46 | Human | Oral cavity | OSCC | 8.10e-06 | 1.90e-01 | 0.1666 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0016032111 | Esophagus | ESCC | viral process | 301/8552 | 415/18723 | 3.34e-29 | 1.32e-26 | 301 |
GO:0019058111 | Esophagus | ESCC | viral life cycle | 226/8552 | 317/18723 | 1.17e-20 | 1.76e-18 | 226 |
GO:0044403111 | Esophagus | ESCC | biological process involved in symbiotic interaction | 186/8552 | 290/18723 | 1.43e-10 | 4.16e-09 | 186 |
GO:0051701111 | Esophagus | ESCC | biological process involved in interaction with host | 135/8552 | 203/18723 | 1.49e-09 | 3.49e-08 | 135 |
GO:0052126111 | Esophagus | ESCC | movement in host environment | 117/8552 | 175/18723 | 1.14e-08 | 2.26e-07 | 117 |
GO:00510908 | Esophagus | ESCC | regulation of DNA-binding transcription factor activity | 252/8552 | 440/18723 | 5.22e-07 | 6.97e-06 | 252 |
GO:0044409111 | Esophagus | ESCC | entry into host | 96/8552 | 151/18723 | 6.73e-06 | 6.84e-05 | 96 |
GO:003320914 | Esophagus | ESCC | tumor necrosis factor-mediated signaling pathway | 67/8552 | 99/18723 | 7.87e-06 | 7.72e-05 | 67 |
GO:003461220 | Esophagus | ESCC | response to tumor necrosis factor | 149/8552 | 253/18723 | 1.47e-05 | 1.33e-04 | 149 |
GO:004671827 | Esophagus | ESCC | viral entry into host cell | 89/8552 | 144/18723 | 6.84e-05 | 5.18e-04 | 89 |
GO:007135620 | Esophagus | ESCC | cellular response to tumor necrosis factor | 132/8552 | 229/18723 | 1.69e-04 | 1.11e-03 | 132 |
GO:004211018 | Esophagus | ESCC | T cell activation | 256/8552 | 487/18723 | 1.18e-03 | 5.87e-03 | 256 |
GO:00434332 | Esophagus | ESCC | negative regulation of DNA-binding transcription factor activity | 103/8552 | 185/18723 | 3.86e-03 | 1.57e-02 | 103 |
GO:001603220 | Oral cavity | OSCC | viral process | 274/7305 | 415/18723 | 2.42e-29 | 1.70e-26 | 274 |
GO:001905820 | Oral cavity | OSCC | viral life cycle | 208/7305 | 317/18723 | 4.59e-22 | 1.00e-19 | 208 |
GO:004440320 | Oral cavity | OSCC | biological process involved in symbiotic interaction | 173/7305 | 290/18723 | 6.80e-13 | 3.19e-11 | 173 |
GO:005170120 | Oral cavity | OSCC | biological process involved in interaction with host | 125/7305 | 203/18723 | 5.60e-11 | 1.74e-09 | 125 |
GO:005212620 | Oral cavity | OSCC | movement in host environment | 106/7305 | 175/18723 | 5.84e-09 | 1.26e-07 | 106 |
GO:003461218 | Oral cavity | OSCC | response to tumor necrosis factor | 143/7305 | 253/18723 | 1.09e-08 | 2.23e-07 | 143 |
GO:007135618 | Oral cavity | OSCC | cellular response to tumor necrosis factor | 128/7305 | 229/18723 | 1.49e-07 | 2.49e-06 | 128 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TNFRSF4 | SNV | Missense_Mutation | novel | c.203G>A | p.Gly68Glu | p.G68E | P43489 | protein_coding | tolerated(1) | benign(0.001) | TCGA-CR-6477-01 | Oral cavity | head & neck squamous cell carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | SD |
TNFRSF4 | SNV | Missense_Mutation | c.346N>A | p.Leu116Met | p.L116M | P43489 | protein_coding | tolerated(0.22) | benign(0.006) | TCGA-CH-5739-01 | Prostate | prostate adenocarcinoma | Male | >=65 | 7 | Unknown | Unknown | SD | |
TNFRSF4 | SNV | Missense_Mutation | c.496N>C | p.Cys166Arg | p.C166R | P43489 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-CD-A4MG-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
TNFRSF4 | insertion | Frame_Shift_Ins | novel | c.548_549insC | p.Ala184GlyfsTer10 | p.A184Gfs*10 | P43489 | protein_coding | TCGA-HF-7132-01 | Stomach | stomach adenocarcinoma | Male | Unknown | I/II | Chemotherapy | fluorouracil | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
7293 | TNFRSF4 | DRUGGABLE GENOME, CELL SURFACE, EXTERNAL SIDE OF PLASMA MEMBRANE | PF-04518600 | IVUXOLIMAB | ||
7293 | TNFRSF4 | DRUGGABLE GENOME, CELL SURFACE, EXTERNAL SIDE OF PLASMA MEMBRANE | 315661177 | |||
7293 | TNFRSF4 | DRUGGABLE GENOME, CELL SURFACE, EXTERNAL SIDE OF PLASMA MEMBRANE | antibody | 315661320 | VONLEROLIZUMAB | |
7293 | TNFRSF4 | DRUGGABLE GENOME, CELL SURFACE, EXTERNAL SIDE OF PLASMA MEMBRANE | GBR 830 | |||
7293 | TNFRSF4 | DRUGGABLE GENOME, CELL SURFACE, EXTERNAL SIDE OF PLASMA MEMBRANE | Anti-OX40 mab | |||
7293 | TNFRSF4 | DRUGGABLE GENOME, CELL SURFACE, EXTERNAL SIDE OF PLASMA MEMBRANE | 178101769 | |||
7293 | TNFRSF4 | DRUGGABLE GENOME, CELL SURFACE, EXTERNAL SIDE OF PLASMA MEMBRANE | MEDI0562 | TAVOLIMAB | ||
7293 | TNFRSF4 | DRUGGABLE GENOME, CELL SURFACE, EXTERNAL SIDE OF PLASMA MEMBRANE | INCAGN1949 | |||
7293 | TNFRSF4 | DRUGGABLE GENOME, CELL SURFACE, EXTERNAL SIDE OF PLASMA MEMBRANE | TRemelimumab + MEDI0562 |
Page: 1 |